英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
TGFβRI-IN-3 |
|
2763602-67-9 |
詳細(xì)
|
PD184161 |
|
212631-67-9 |
詳細(xì)
|
MRT-81 |
|
1263132-08-6 |
詳細(xì)
|
M2N12 |
|
2376577-06-7 |
詳細(xì)
|
Zolbetuximab |
佐妥昔單抗 |
1496553-00-4 |
詳細(xì)
|
Cofetuzumab |
考非妥珠單抗 |
1869928-62-0 |
詳細(xì)
|
M435-1279 |
|
1359431-16-5 |
詳細(xì)
|
DATP-N3 |
|
1048021-78-8 |
詳細(xì)
|
AA38-3 |
|
65815-76-1 |
詳細(xì)
|
Mosunetuzumab |
莫妥珠單抗 |
1905409-39-3 |
詳細(xì)
|
Tiragolumab |
替瑞利尤單抗 |
1918185-84-8 |
詳細(xì)
|
Romilkimab |
若奇單抗 |
1399584-78-1 |
詳細(xì)
|
2-Deoxy-2-fluoro-D-galactose |
2-氟-alfa-d-2-脫氧-葡萄糖 |
7226-39-3 |
詳細(xì)
|
6-Chloropurine -9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside |
6-氯-9-(3,5-二-O-苯甲酰基-2-脫氧-2-氟-BETA-D-阿拉伯呋喃糖基)-9H-嘌呤 |
135473-15-3 |
詳細(xì)
|
N-Desmethyltamoxifen |
去甲基他莫昔芬 |
31750-48-8 |
詳細(xì)
|
DUBs-IN-2 |
|
924296-19-5 |
詳細(xì)
|
SP141 |
|
1253491-42-7 |
詳細(xì)
|
Esomeprazole Impurity 3 |
埃索美拉唑雜質(zhì)3 |
1346599-85-6 |
詳細(xì)
|
KGP94 |
|
1131456-28-4 |
詳細(xì)
|
MP07-66 |
|
1938056-90-6 |
詳細(xì)
|
Gedivumab |
格迪伏單抗 |
1807954-17-1 |
詳細(xì)
|
Lacnotuzumab |
拉妥珠單抗 |
1831128-32-5 |
詳細(xì)
|
Tislelizumab |
替雷利珠單抗 |
1858168-59-8 |
詳細(xì)
|
Ladiratuzumab |
|
1629760-28-6 |
詳細(xì)
|
Netakimab |
尼塔奇單抗 |
1796570-08-5 |
詳細(xì)
|
SGK1-IN-4 |
|
1628048-93-0 |
詳細(xì)
|
WQ 1 |
|
1204401-49-9 |
詳細(xì)
|
Paprotrain |
|
57046-73-8 |
詳細(xì)
|
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-6-ol |
6,7-二氫-5H-吡咯并[1,2-A]咪唑-6-醇 |
1378606-06-4 |
詳細(xì)
|
PI-273 |
|
925069-34-7 |
詳細(xì)
|
Talacotuzumab |
塔妥珠單抗 |
1826831-79-1 |
詳細(xì)
|
Prasinezumab |
普尼珠單抗 |
1960462-19-4 |
詳細(xì)
|
(3S)-3-(2,2,2-Trifluoroethyl)pyrrolidine |
(3S)-3-(2,2,2-三氟乙基)吡咯烷 |
1430091-57-8 |
詳細(xì)
|
KA2507 |
|
1636894-46-6 |
詳細(xì)
|
SBP3264 |
|
|
詳細(xì)
|
Calmidazolium chloride |
鈣調(diào)蛋白抑制劑 |
57265-65-3 |
詳細(xì)
|
SU16f |
|
251356-45-3 |
詳細(xì)
|
L002 |
|
321695-57-2 |
詳細(xì)
|
R-Avanafil |
R-阿伐那非 |
1638497-26-3 |
詳細(xì)
|
NDMC101 |
|
1308631-40-4 |
詳細(xì)
|
JJKK048 |
|
1515855-97-6 |
詳細(xì)
|
TC-FPR 43 |
|
903895-98-7 |
詳細(xì)
|
ML328 |
|
634175-34-1 |
詳細(xì)
|
M-525 |
|
2173582-08-4 |
詳細(xì)
|
Selicrelumab |
塞魯單抗 |
1622140-49-1 |
詳細(xì)
|
Spartalizumab |
斯巴達(dá)珠單抗 |
1935694-88-4 |
詳細(xì)
|
Iladatuzumab |
|
1906205-76-2 |
詳細(xì)
|
Ontamalimab |
昂塔利單抗 |
2098790-40-8 |
詳細(xì)
|
SB-747651A |
|
607372-46-3 |
詳細(xì)
|
CDK4/6-IN-6 |
|
2380321-51-5 |
詳細(xì)
|
BMS-986122 |
|
313669-88-4 |
詳細(xì)
|
WAY-204688 |
|
796854-35-8 |
詳細(xì)
|
PA 452 |
|
457657-34-0 |
詳細(xì)
|
SPP-86 |
|
1357349-91-7 |
詳細(xì)
|
2-Oxa-6,9-diazaspiro[4.5]decane-6-carboxylic acid, 1,1-dimethylethyl ester |
2-氧雜-6,9-二氮雜螺[4.5]癸烷-6-羧酸叔丁酯 |
1784402-13-6 |
詳細(xì)
|
Azintuxizumab |
阿妥昔珠單抗 |
1826819-57-1 |
詳細(xì)
|
Ianalumab |
伊利尤單抗 |
1929549-92-7 |
詳細(xì)
|
Atidortoxumab |
阿度尤單抗 |
1939108-95-8 |
詳細(xì)
|
Relatlimab |
瑞拉利單抗 |
1673516-98-7 |
詳細(xì)
|
Cusatuzumab |
古妥珠單抗 |
1399546-01-0 |
詳細(xì)
|
8-Bromo-3-chloro-5-isopropylisoquinoline |
8-溴-3-氯-5-異丙基異喹啉 |
2660255-85-4 |
詳細(xì)
|
MAO-B-IN-2 |
|
1253978-24-3 |
詳細(xì)
|
Tafluprost Impurity 16Z |
他氟前列素16Z型雜質(zhì) |
|
詳細(xì)
|
CAY10574 |
|
140651-18-9 |
詳細(xì)
|
Diprotin A |
抑二肽素A |
90614-48-5 |
詳細(xì)
|
RO-9187 |
|
876708-03-1 |
詳細(xì)
|
MRT10 |
|
330829-30-6 |
詳細(xì)
|
SM-7368 |
|
380623-76-7 |
詳細(xì)
|
Sappanone A |
蘇木酮A |
102067-84-5 |
詳細(xì)
|
SB-747651A dihydrochloride |
|
1781882-72-1 |
詳細(xì)
|
GSK1379725A |
|
1802251-00-8 |
詳細(xì)
|
PP7 |
|
433238-84-7 |
詳細(xì)
|
Alkyne tyramide |
|
1694495-59-4 |
詳細(xì)
|
Frunevetmab |
夫盧維單抗 |
1708936-80-4 |
詳細(xì)
|
Sirtratumab |
斯妥尤單抗 |
1824663-82-2 |
詳細(xì)
|
Bemarituzumab |
貝馬里妥珠單抗 |
1952272-74-0 |
詳細(xì)
|
Tibulizumab |
替布利珠單抗 |
1849636-24-3 |
詳細(xì)
|
NLG802 |
|
2071683-99-1 |
詳細(xì)
|
SC-1 |
|
1313019-65-6 |
詳細(xì)
|
STAT5-IN-2 |
|
2111834-61-6 |
詳細(xì)
|
Mirikizumab |
米吉珠單抗 |
1884201-71-1 |
詳細(xì)
|
Fenquizone |
芬喹唑 |
20287-37-0 |
詳細(xì)
|
azidamfenicol |
疊氮氯霉素 |
13838-08-9 |
詳細(xì)
|
GLUT inhibitor-1 |
|
2421141-40-2 |
詳細(xì)
|
GSK215 |
|
2743427-26-9 |
詳細(xì)
|
EN523 |
|
2094893-05-5 |
詳細(xì)
|
GSK 2256294A |
|
1142090-23-0 |
詳細(xì)
|
YK-3-237 |
|
1215281-19-8 |
詳細(xì)
|
4'-C-Fluoro-uridine |
|
1613589-24-4 |
詳細(xì)
|
Loncastuximab |
朗妥昔單抗 |
1875032-68-0 |
詳細(xì)
|
Berlimatoxumab |
貝度尤單抗 |
1939109-24-6 |
詳細(xì)
|
Crovalimab |
可伐利單抗 |
1917321-26-6 |
詳細(xì)
|
Faricimab |
法瑞西單抗 |
1607793-29-2 |
詳細(xì)
|
BAZ1A-IN-1 |
|
941521-45-5 |
詳細(xì)
|
Nitromazenil |
|
84377-97-9 |
詳細(xì)
|
CJ033466 |
|
519148-48-2 |
詳細(xì)
|
SR 13800 |
|
227321-12-2 |
詳細(xì)
|
Lesofavumab |
來索伏單抗 |
1807960-57-1 |
詳細(xì)
|
Gimsilumab |
瑾司魯單抗 |
1648796-29-5 |
詳細(xì)
|
Zenocutuzumab |
澤妥珠單抗 |
1969309-56-5 |
詳細(xì)
|